Medicinal and Botanical Manufacturing contracts ending at National Institutes of Health
Department of Health and Human Services
3 contracts of $100,000 or more under NAICS 325411, medicinal and botanical manufacturing, at National Institutes of Health end in the next 18 months, with $1.7M obligated so far.
- Ending in 18 months
- 3 contracts$1.7M obligated so far
- Biggest holder
- Curia Global Inc$908K on 1 contract ending soon
- Open notices
- NAICS 325411contract opportunities open now
- Source
- USAspending.govUpdated Nov 17, 2026, 7:37 PM UTC
Contracts ending soon
Soonest end first. Each contract links to its record on USAspending.gov.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| Analytical Method Development, Validation and Stability Study of Orc-13661Mriglobal · 75N95022F00002 | $482,032 | Jun 30, 2027in 7 months | MO |
| Process Development and Manufacture of AZM152Polypeptide Laboratories San Diego, LLC · 75N95026F00001 | $315,000 | Sep 16, 2027in 9 months | CA |
| Chemistry, Manufacturing, and Controls (Cmc) Development of NCGC00413972 for Preclinical Safety Evaluation and Clinical TrialCuria Global Inc · 75N95023F00001 | $907,792 | Apr 30, 2028in 17 months | NY |
End dates are the current period of performance; options not yet exercised can extend them. An ending contract may be competed again, extended, or moved to another vehicle. BPA calls and orders shorter than six months are left out. Department of Defense contracts appear on USAspending.gov about 90 days after award.
Get new notices under NAICS 325411
New contract opportunities under NAICS 325411, medicinal and botanical manufacturing, the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy